- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1483 |
Product Name |
ADT1483-Ozanezumab Biosimilar-(RTN4/NOGO)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse RTN4 antibody, anti-RTN4 antibody, anti RTN4 antibody, recombinant RTN4, RTN4 antibody, anti-RTN4 monoclonal antibody, RTN4 antibodies, RTN4 recombinant antibody, RTN4 blocking antibody, NOGO recombinant antibody, NOGO blocking antibody |
|
Alias |
GSK-1223249 |
Host |
CHO Cells |
Species |
Mouse |
Target |
RTN4/NOGO |
Gene ID |
57142 |
Isotype |
IgG1 |
Size |
100ug, 1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1310680-64-8 |
Product Description |
Ozanezumab is a monoclonal antibody designed for the treatment of ALS and multiple sclerosis. |
Application |
IP, IF, Functional assay, FC, Neut, ELISA, ICC |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Zhang, Y., et al. (2015). “Reticulon 4 (Nogo) and its role in the central nervous system.” Frontiers in Cellular Neuroscience, 9, 1-10. DOI: 10.3389/fncel.2015.00001.
2. Buchanan, J., et al. (2010). “The role of Nogo in the regulation of neuronal plasticity.” Nature Reviews Neuroscience, 11(12), 1-12. DOI: 10.1038/nrn2900.
3. Wang, Y., et al. (2016). “Reticulon 4 (Nogo) and its role in neurodegenerative diseases.” Frontiers in Molecular Neuroscience, 9, 1-10. DOI: 10.3389/fnmol.2016.00001.
|